Role of brain-derived neurotrophic factor in wobbler mouse motor neuron disease

被引:33
作者
Tsuzaka, K [1 ]
Ishiyama, T [1 ]
Pioro, EP [1 ]
Mitsumoto, H [1 ]
机构
[1] Cleveland Clin Fdn, Dept Neurol & Neurosci, Cleveland, OH 44195 USA
关键词
brain-derived neurotrophic factor; motoneuron; motor neuron disease; neurotrophic factor; nitric oxide synthase;
D O I
10.1002/mus.1029
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Brain-derived neurotrophic factor (BDNF) is neuroprotective for motoneurons undergoing degeneration, including those in natural motor neuron disease (MND) in wobbler mice. To assess the role of BDNF in this model of MND, endogenous BDNF immunoreactivity was analyzed by semiquantitative video-image analysis. Affected cervical spinal cord motoneurons had significantly greater BDNF immunoreactivity compared to motoneurons of healthy littermates (P = 0.01) and affected lumbar spinal cord motoneurons (P = 0.008 at age 4 weeks; P = 0.005 at age 8 weeks). Neuronal nitric oxide synthase (n-NOS) immunocytochemistry revealed increased immunoreactivity in the affected cervical spinal cord motoneurons. Exogenous BDNF treatment partially inhibited the increased NOS activity, as quantitatively measured by nicotinamide adenine dinucleotide phosphate diaphorase (NADPH-d) histochemistry. The mean number of NADPH-d(+) motoneurons in the cervical anterior horn decreased from 3.5 =/- 1.2 to 1.5 +/- 1.2 (P = 0.002), The increase in endogenous BDNF immunoreactivity in the affected spinal cord may be compensatory in diseased motoneurons, yet it appears to still be inadequate because exogenous BDNF treatment is required to suppress increased NOS activity in degenerating motoneurons. Our study indicates that BDNF is important in halting nitric oxide (NO)mediated motor neuron degeneration, which has potential implications for the treatment of neurodegenerative disorders. (C) 2001 John Wiley & Sons, Inc.
引用
收藏
页码:474 / 480
页数:7
相关论文
共 45 条
[1]   INDUCTION OF NITROTYROSINE-LIKE IMMUNOREACTIVITY IN THE LOWER MOTOR-NEURON OF AMYOTROPHIC-LATERAL-SCLEROSIS [J].
ABE, K ;
PAN, LH ;
WATANABE, M ;
KATO, T ;
ITOYAMA, Y .
NEUROSCIENCE LETTERS, 1995, 199 (02) :152-154
[2]  
ANDREWS JM, 1974, AM J PATHOL, V76, P63
[3]  
BEAL MF, 1997, ANN NEUROL, V42, P646
[4]   ALS, SOD AND PEROXYNITRITE [J].
BECKMAN, JS ;
CARSON, M ;
SMITH, CD ;
KOPPENOL, WH .
NATURE, 1993, 364 (6438) :584-584
[5]   A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis [J].
Borasio, GD ;
Robberecht, W ;
Leigh, PN ;
Emile, J ;
Guiloff, RJ ;
Jerusalem, F ;
Silani, V ;
Vos, PE ;
Wokke, JHJ ;
Dobbins, T .
NEUROLOGY, 1998, 51 (02) :583-586
[6]   AMYOTROPHIC-LATERAL-SCLEROSIS - RECENT INSIGHTS FROM GENETICS AND TRANSGENIC MICE [J].
BROWN, RH .
CELL, 1995, 80 (05) :687-692
[7]  
Cedarbaum JM, 2000, NEUROLOGY, V54, pA342
[8]   Expression of nitric oxide synthase by motor neurones in the spinal cord of the mutant mouse wobbler [J].
Clowry, GJ ;
McHanwell, S .
NEUROSCIENCE LETTERS, 1996, 215 (03) :177-180
[9]   AXOTOMY INDUCES NADPH DIAPHORASE ACTIVITY IN NEONATAL BUT NOT ADULT MOTONEURONS [J].
CLOWRY, GJ .
NEUROREPORT, 1993, 5 (03) :361-364
[10]   NITRIC-OXIDE SYNTHASE AND NEURONAL NADPH DIAPHORASE ARE IDENTICAL IN BRAIN AND PERIPHERAL-TISSUES [J].
DAWSON, TM ;
BREDT, DS ;
FOTUHI, M ;
HWANG, PM ;
SNYDER, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (17) :7797-7801